Diagnostic AI Tool for Identifying Early-Stage Lung Cancer Earns FDA 150(k) Clearance

Retrieved on: 2021-03-24 16:08:43

Tags for this article:

Click the tags to see associated articles and topics

Diagnostic AI Tool for Identifying Early-Stage Lung Cancer Earns FDA 150(k) Clearance. View article details on hiswai:

Excerpt

FDA 150(k) clearance was granted to the artificial intelligence (AI)–powered clinical decision support software Virtual Nodule Clinic for use by ...

Article found on: www.cancernetwork.com